Oxford University Press

SHERPA: Yellow

People

  1. De Angelis
    De Angelis
  2. Kaley
    Kaley
  3. Mellinghoff
    Mellinghoff
  4. Pentsova
    Pentsova
  5. Nolan
    Nolan
  6. Gavrilovic
    Gavrilovic
  7. Panageas
    Panageas
  8. Grommes
    Grommes
  9. Gutin
    Gutin
  10. Karimi
    Karimi

Groups

  1. Tow Center for Developmental Oncology (TCDO) (25)
  2. GSK Faculty (13)
  3. Human Oncology and Pathogenesis Program (12)
  4. Neuroradiology Service (8)
  5. Radiology, Department of (8)
  6. Biostatistics Service (7)
  7. Epidemiology and Biostatistics (7)
  8. Population Sciences Research Program (7)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (5)
  10. Center for Hematologic Malignancies (4)
Search Within
  1. "Antonio Omuro"
  2. "Lisa De Angelis"
Formats
  1. Meeting Abstract (18)
  2. Journal Article (7)
Groups
  1. Tow Center for Developmental Oncology (TCDO) (25)
  2. GSK Faculty (13)
  3. Human Oncology and Pathogenesis Program (12)
  4. Neuroradiology Service (8)
  5. Radiology, Department of (8)
  6. Biostatistics Service (7)

More Groups

People
  1. Antonio Omuro (25)
  2. Lisa De Angelis (25)
  3. Thomas Kaley (13)
  4. Elena Pentsova (9)
  5. Ingo Mellinghoff (9)
  6. Craig Nolan (8)

More People

Years
  1. 2017 (3)
  2. 2016 (3)
  3. 2014 (3)
  4. 2013 (5)
  5. 2012 (6)
  6. 2011 (4)

More Years

Publications
  1. Neuro-Oncology (24)
  2. Annals of Oncology (1)

Results (25)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cerebrospinal fluid circulating tumor cells: A novel tool to diagnose leptomeningeal metastases from epithelial tumors
    Journal Article

    Lin, X.; Fleisher, M.; Rosenblum, M.; Lin, O.; Boire, A.; Briggs, S.; Bensman, Y.; Hurtado, B.; Shagabayeva, L.; DeAngelis, L. M.; more...
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma
    Journal Article

    Thomas, A. A.; Abrey, L. E.; Terziev, R.; Raizer, J.; Martinez, N. L.; Forsyth, P.; Paleologos, N.; Matasar, M.; Sauter, C. S.; Moskowitz, C.; more...
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Cerebrospinal fluid circulating tumor cells: A novel tool to diagnose leptomeningeal metastases from epithelial tumors
    Meeting Abstract

    Pentsova, E.; Lin, X.; Fleisher, M.; Rosenblum, M.; Lin, O.; Boire, A.; Briggs, S.; DeAngelis, L. M.; Panageas, K. S.; Omuro, A.
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Phase I/II study of single agent Ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL)
    Meeting Abstract

    Grommes, C.; Gavrilovic, I.; Kaley, T.; Nolan, C.; Omuro, A.; Wolfe, J.; Pentsova, E.; Hatzoglou, V.; Mellinghoff, I.; DeAngelis, L.
    Neuro-Oncology (2016)

    Fulltext@MSK | Save
  • Phase I/II study of single agent ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL)
    Meeting Abstract

    Grommes, C.; Gavrilovic, I.; Kaley, T.; Nolan, C.; Omuro, A.; Wolfe, J.; Pentsova, E.; Hatzoglou, V.; Mellinghoff, I. K.; Deangelis, L.
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma
    Journal Article

    de la Fuente, M. I.; Young, R. J.; Rubel, J.; Rosenblum, M.; Tisnado, J.; Briggs, S.; Arevalo-Perez, J.; Cross, J. R.; Campos, C.; Straley, K.; more...
    Neuro-Oncology (2016)

    Fulltext@MSK | Save
  • Dynamic contrast-enhanced magnetic resonance perfusion weighted imaging (DCE-MRI) and diffusion weighted imaging (DWI) for pharmacodynamic evaluation of carboxyamidotriazole orotate (CTO) and temozolomide in malignant glioma
    Meeting Abstract

    Magge, R.; Arevalo Perez, J.; Young, R.; Kaley, T.; Pentsova, E.; DeAngelis, L.; Diamond, E.; Mellinghoff, I.; Peck, K.; Anderson, B.; more...
    Neuro-Oncology (2014)

    Fulltext@MSK | Save
  • Intermittent high dose (pulsatile) erlotinib for EGFRvIII mutant recurrent malignant gliomas: A pilot clinical trial
    Meeting Abstract

    Lassman, A.; Grommes, C.; Panageas, K.; Iwamoto, F.; DeAngelis, L.; Kaley, T.; Gavrilovic, I.; Pentsova, E.; Omuro, A.; Corpuz, C.; more...
    Neuro-Oncology (2014)

    Fulltext@MSK | Save
  • Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma
    Journal Article

    Kaley, T. J.; Wen, P.; Schiff, D.; Ligon, K.; Haidar, S.; Karimi, S.; Lassman, A. B.; Nolan, C. P.; De Angelis, L. M.; Gavrilovic, I.; more...
    Neuro-Oncology (2014)

    Fulltext@MSK | Save
  • Phase II trial of the phosphatidyinositol-3 kinase (Pi3k) inhibitor buparlisib (Bkm120) in recurrent glioblastoma: An Ivy Foundation early phase clinical trials consortium study
    Meeting Abstract

    Wen, P.; Yung, A.; Mellinghoff, I.; Lamborn, K.; Ramkissoon, S.; Cloughesy, T.; Rinne, M.; Omuro, A.; DeAngelis, L.; Gilbert, M.; more...
    Neuro-Oncology (2013)

    Fulltext@MSK | Save